Research on metabolic and ketogenic approaches to schizophrenia.
General Metabolic Psychiatry
Key takeaways * The ketogenic diet is a proven medical diet for some types of epilepsy. Its use in mental health is still being researched. * Small studies in depression, bipolar disorder and schizophrenia show encouraging results. * There is no high-quality evidence yet. Larger controlled trials are needed. * Keto can affect
General Metabolic Psychiatry
Key takeaways * Metabolic psychiatry studies how the body's energy systems, like blood sugar and insulin, connect to mental health. * People with serious mental illness have higher rates of metabolic problems than the general population. * Diet changes, including the ketogenic diet, are being studied as add-ons to usual
Schizophrenia
What was studied: Two new papers looked at GLP-1 medicines (the drug family that includes semaglutide) in people with schizophrenia, who often gain weight and develop blood sugar problems on antipsychotic medication. The first pooled 7 randomized trials with 481 people taking antipsychotics. The second used Danish national health
General Metabolic Psychiatry
What it is: A short 2025 interview from Stanford Medicine with psychiatrist and obesity specialist Dr. Shebani Sethi, who led a 2024 pilot study of a ketogenic diet in schizophrenia and bipolar disorder. What it says: In that pilot, 21 adults followed the diet for four months alongside their usual